Home > Back to Publisher > Report Information

OTC Healthcare in Greece to 2011

Datamonitor
August 5, 2008
183 Pages - SKU: DFMN1872841

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Greece

Introduction

This databook is a detailed information resource covering all the key data points on OTC Healthcare in Greece. It includes comprehensive value volume segmentation and market share data. The databook supplies actual data to 2006 and full forecasts to 2011.

Scope

Contains information on:Analgesics,Cough & cold,Indigestion,Medicated skin products,Traditional medicines,Vitamins & Other OTC healthcare products
Provides market value, volume, expenditure and consumption data by market, segment and subsegment
Includes company and brand share data by categories

Highlights

The market for OTC Healthcare in Greece increased between 2001-2006, growing at an average annual rate of 5.9%.

The leading company in the market in 2006 was Pfizer Inc. The second-largest player was Korres Natural Products S.A. with Bayer AG in third place.

Reasons to Purchase

Discover the major quantitative trends affecting the OTC Healthcare markets
Understand consumers' consumption and expenditure patterns
Understand the future direction of the market with reliable historical data and full five year forecasting

Additional Information

Databooks are a detailed information resource covering all the key data points across all industry verticals. They provide data covering a particular market at country or regional level in comprehensive tabular and brief contextual format. The databook allows the user to study and analyze the data. This databook is comprised of an overview chapter covering the market as a whole, a chapter examining each category within the market, and a chapter containing socioeconomic analysis and data. It also includes a chapter detailing Datamonitor’s research methodology, and an appendix containing additional details.

Chapter 1 EXECUTIVE SUMMARY
: Summary Market Level - OTC Healthcare; Summary category level - Analgesics; Summary category level - Cough and Cold Preparations; Summary category level - Traditional Medicines; Summary category level - First Aid Kits; Summary category level - Indigestion Preparations; Summary category level - Vitamins and Minerals; Summary category level - Plasters & Bandages; Summary category level - Medicated Skin Products; Summary category level - Other OTC Healthcare Products; Summary category level - Topical OTC Medicines
Chapter 2 INTRODUCTION
: What is this report about?; How to use this report; Market Definition
Chapter 3 MARKET OVERVIEW
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 4 LEADING COMPANY PROFILES
: Pfizer Inc
Chapter 5 CATEGORY ANALYSIS - ANALGESICS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 6 CATEGORY ANALYSIS - COUGH AND COLD PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 7 CATEGORY ANALYSIS - TRADITIONAL MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 8 CATEGORY ANALYSIS - FIRST AID KITS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 9 CATEGORY ANALYSIS - INDIGESTION PREPARATIONS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 10 CATEGORY ANALYSIS - VITAMINS AND MINERALS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 11 CATEGORY ANALYSIS - PLASTERS & BANDAGES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 12 CATEGORY ANALYSIS - MEDICATED SKIN PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 13 CATEGORY ANALYSIS - OTHER OTC HEALTHCARE PRODUCTS
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 14 CATEGORY ANALYSIS - TOPICAL OTC MEDICINES
: Value Analysis, 2001-2006; Value Analysis, 2006-2011; Value Analysis, US$ 2001-2006; Value Analysis, US$ 2006-2011; Company and Brand Share Analysis; Expenditure & consumption per capita
Chapter 15 COUNTRY COMPARISON
: Value; Market Share
Chapter 16 NEW PRODUCT DEVELOPMENT
: Product launches over time; Recent product launches
Chapter 17 GREECE SOCIOECONOMIC PROFILE
: Country Overview; Key Facts; Political Overview; Greece Economic Overview
Chapter 18 GREECE MACROECONOMIC PROFILE
: Macroeconomic Indicators
Chapter 19 RESEARCH METHODOLOGY
: Methodology overview; Secondary research; Market modelling; Primary research; Data finalisation; Ongoing research
Chapter 20 APPENDIX
: Future readings; How to contact experts in your industry
LIST OF FIGURES
: Figure 1: Greece OTC Healthcare value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 2: Greece OTC Healthcare category growth comparison, by value, 2001-2011; Figure 3: Greece OTC Healthcare company share, by value, 2005-2006 (%); Figure 4: Greece Analgesics value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 5: Greece Analgesics category growth comparison, by value, 2001-2011; Figure 6: Greece Analgesics company share, by value, 2005-2006 (%); Figure 7: Greece Cough and Cold Preparations value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 8: Greece Cough and Cold Preparations category growth comparison, by value, 2001-2011; Figure 9: Greece Cough and Cold Preparations company share, by value, 2005-2006 (%); Figure 10: Greece Traditional Medicines value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 11: Greece First Aid Kits value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 12: Greece First Aid Kits company share, by value, 2005-2006 (%); Figure 13: Greece Indigestion Preparations value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 14: Greece Indigestion Preparations category growth comparison, by value, 2001-2011; Figure 15: Greece Indigestion Preparations company share, by value, 2005-2006 (%); Figure 16: Greece Vitamins and Minerals value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 17: Greece Vitamins and Minerals category growth comparison, by value, 2001-2011; Figure 18: Greece Vitamins and Minerals company share, by value, 2005-2006 (%); Figure 19: Greece Plasters & Bandages value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 20: Greece Plasters & Bandages category growth comparison, by value, 2001-2011; Figure 21: Greece Plasters & Bandages company share, by value, 2005-2006 (%); Figure 22: Greece Medicated Skin Products value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 23: Greece Medicated Skin Products category growth comparison, by value, 2001-2011; Figure 24: Greece Medicated Skin Products company share, by value, 2005-2006 (%); Figure 25: Greece Other OTC Healthcare Products value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 26: Greece Other OTC Healthcare Products category growth comparison, by value, 2001-2011; Figure 27: Greece Other OTC Healthcare Products company share, by value, 2005-2006 (%); Figure 28: Greece Topical OTC Medicines value & value forecast, 2001-2011 (EUR m, nominal prices); Figure 29: Greece Topical OTC Medicines category growth comparison, by value, 2001-2011; Figure 30: Global OTC Healthcare market split (value terms, 2006) - Top 5 countries; Figure 31: Global OTC Healthcare market value, 2001 - 2006 (Top 5 countries); Figure 32: Map of Greece; Figure 33: Annual data review process
LIST OF TABLES
: Table 1: OTC Healthcare category definitions; Table 2: Greece OTC Healthcare value, 2001-2006 (EUR m, nominal prices); Table 3: Greece OTC Healthcare value forecast, 2006-2011 (EUR m, nominal prices); Table 4: Greece OTC Healthcare value, 2001-2006 (US$ m nominal prices); Table 5: Greece OTC Healthcare value forecast, 2006-2011 (US$ m nominal prices); Table 6: Greece OTC Healthcare brand share, by value, 2005-2006 (%); Table 7: Greece OTC Healthcare value, by brand 2005-2006 (EUR m nominal prices); Table 8: Greece OTC Healthcare company share by value, 2005-2006 (%); Table 9: Greece OTC Healthcare value, by company, 2005-2006 (EUR m nominal prices); Table 10: Greece OTC Healthcare expenditure per capita, 2001-2006 (EUR, nominal prices); Table 11: Greece OTC Healthcare forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 12: Greece OTC Healthcare expenditure per capita, 2001-2006 (US$ nominal prices); Table 13: Greece OTC Healthcare forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 14: Pfizer Inc Key Facts; Table 15: Greece Analgesics value, 2001-2006 (EUR m, nominal prices); Table 16: Greece Analgesics value forecast, 2006-2011 (EUR m, nominal prices); Table 17: Greece Analgesics value, 2001-2006 (US$ m nominal prices); Table 18: Greece Analgesics value forecast, 2006-2011 (US$ m nominal prices); Table 19: Greece Analgesics brand share, by value, 2005-2006 (%); Table 20: Greece Analgesics value, by brand 2005-2006 (EUR m nominal prices); Table 21: Greece Analgesics company share by value, 2005-2006 (%); Table 22: Greece Analgesics value, by company, 2005-2006 (EUR m nominal prices); Table 23: Greece Analgesics expenditure per capita, 2001-2006 (EUR, nominal prices); Table 24: Greece Analgesics forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 25: Greece Analgesics expenditure per capita, 2001-2006 (US$ nominal prices); Table 26: Greece Analgesics forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 27: Greece Cough and Cold Preparations value, 2001-2006 (EUR m, nominal prices); Table 28: Greece Cough and Cold Preparations value forecast, 2006-2011 (EUR m, nominal prices); Table 29: Greece Cough and Cold Preparations value, 2001-2006 (US$ m nominal prices); Table 30: Greece Cough and Cold Preparations value forecast, 2006-2011 (US$ m nominal prices); Table 31: Greece Cough and Cold Preparations brand share, by value, 2005-2006 (%); Table 32: Greece Cough and Cold Preparations value, by brand 2005-2006 (EUR m nominal prices); Table 33: Greece Cough and Cold Preparations company share by value, 2005-2006 (%); Table 34: Greece Cough and Cold Preparations value, by company, 2005-2006 (EUR m nominal prices); Table 35: Greece Cough and Cold Preparations expenditure per capita, 2001-2006 (EUR, nominal prices); Table 36: Greece Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 37: Greece Cough and Cold Preparations expenditure per capita, 2001-2006 (US$ nominal prices); Table 38: Greece Cough and Cold Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 39: Greece Traditional Medicines value, 2001-2006 (EUR m, nominal prices); Table 40: Greece Traditional Medicines value forecast, 2006-2011 (EUR m, nominal prices); Table 41: Greece Traditional Medicines value, 2001-2006 (US$ m nominal prices); Table 42: Greece Traditional Medicines value forecast, 2006-2011 (US$ m nominal prices); Table 43: Greece Traditional Medicines brand share, by value, 2005-2006 (%); Table 44: Greece Traditional Medicines value, by brand 2005-2006 (EUR m nominal prices); Table 45: Greece Traditional Medicines company share by value, 2005-2006 (%); Table 46: Greece Traditional Medicines value, by company, 2005-2006 (EUR m nominal prices); Table 47: Greece Traditional Medicines expenditure per capita, 2001-2006 (EUR, nominal prices); Table 48: Greece Traditional Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 49: Greece Traditional Medicines expenditure per capita, 2001-2006 (US$ nominal prices); Table 50: Greece Traditional Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 51: Greece First Aid Kits value, 2001-2006 (EUR m, nominal prices); Table 52: Greece First Aid Kits value forecast, 2006-2011 (EUR m, nominal prices); Table 53: Greece First Aid Kits value, 2001-2006 (US$ m nominal prices); Table 54: Greece First Aid Kits value forecast, 2006-2011 (US$ m nominal prices); Table 55: Greece First Aid Kits brand share, by value, 2005-2006 (%); Table 56: Greece First Aid Kits value, by brand 2005-2006 (EUR m nominal prices); Table 57: Greece First Aid Kits company share by value, 2005-2006 (%); Table 58: Greece First Aid Kits value, by company, 2005-2006 (EUR m nominal prices); Table 59: Greece First Aid Kits expenditure per capita, 2001-2006 (EUR, nominal prices); Table 60: Greece First Aid Kits forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 61: Greece First Aid Kits expenditure per capita, 2001-2006 (US$ nominal prices); Table 62: Greece First Aid Kits forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 63: Greece Indigestion Preparations value, 2001-2006 (EUR m, nominal prices); Table 64: Greece Indigestion Preparations value forecast, 2006-2011 (EUR m, nominal prices); Table 65: Greece Indigestion Preparations value, 2001-2006 (US$ m nominal prices); Table 66: Greece Indigestion Preparations value forecast, 2006-2011 (US$ m nominal prices); Table 67: Greece Indigestion Preparations brand share, by value, 2005-2006 (%); Table 68: Greece Indigestion Preparations value, by brand 2005-2006 (EUR m nominal prices); Table 69: Greece Indigestion Preparations company share by value, 2005-2006 (%); Table 70: Greece Indigestion Preparations value, by company, 2005-2006 (EUR m nominal prices); Table 71: Greece Indigestion Preparations expenditure per capita, 2001-2006 (EUR, nominal prices); Table 72: Greece Indigestion Preparations forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 73: Greece Indigestion Preparations expenditure per capita, 2001-2006 (US$ nominal prices); Table 74: Greece Indigestion Preparations forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 75: Greece Vitamins and Minerals value, 2001-2006 (EUR m, nominal prices); Table 76: Greece Vitamins and Minerals value forecast, 2006-2011 (EUR m, nominal prices); Table 77: Greece Vitamins and Minerals value, 2001-2006 (US$ m nominal prices); Table 78: Greece Vitamins and Minerals value forecast, 2006-2011 (US$ m nominal prices); Table 79: Greece Vitamins and Minerals brand share, by value, 2005-2006 (%); Table 80: Greece Vitamins and Minerals value, by brand 2005-2006 (EUR m nominal prices); Table 81: Greece Vitamins and Minerals company share by value, 2005-2006 (%); Table 82: Greece Vitamins and Minerals value, by company, 2005-2006 (EUR m nominal prices); Table 83: Greece Vitamins and Minerals expenditure per capita, 2001-2006 (EUR, nominal prices); Table 84: Greece Vitamins and Minerals forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 85: Greece Vitamins and Minerals expenditure per capita, 2001-2006 (US$ nominal prices); Table 86: Greece Vitamins and Minerals forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 87: Greece Plasters & Bandages value, 2001-2006 (EUR m, nominal prices); Table 88: Greece Plasters & Bandages value forecast, 2006-2011 (EUR m, nominal prices); Table 89: Greece Plasters & Bandages value, 2001-2006 (US$ m nominal prices); Table 90: Greece Plasters & Bandages value forecast, 2006-2011 (US$ m nominal prices); Table 91: Greece Plasters & Bandages brand share, by value, 2005-2006 (%); Table 92: Greece Plasters & Bandages value, by brand 2005-2006 (EUR m nominal prices); Table 93: Greece Plasters & Bandages company share by value, 2005-2006 (%); Table 94: Greece Plasters & Bandages value, by company, 2005-2006 (EUR m nominal prices); Table 95: Greece Plasters & Bandages expenditure per capita, 2001-2006 (EUR, nominal prices); Table 96: Greece Plasters & Bandages forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 97: Greece Plasters & Bandages expenditure per capita, 2001-2006 (US$ nominal prices); Table 98: Greece Plasters & Bandages forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 99: Greece Medicated Skin Products value, 2001-2006 (EUR m, nominal prices); Table 100: Greece Medicated Skin Products value forecast, 2006-2011 (EUR m, nominal prices); Table 101: Greece Medicated Skin Products value, 2001-2006 (US$ m nominal prices); Table 102: Greece Medicated Skin Products value forecast, 2006-2011 (US$ m nominal prices); Table 103: Greece Medicated Skin Products brand share, by value, 2005-2006 (%); Table 104: Greece Medicated Skin Products value, by brand 2005-2006 (EUR m nominal prices); Table 105: Greece Medicated Skin Products company share by value, 2005-2006 (%); Table 106: Greece Medicated Skin Products value, by company, 2005-2006 (EUR m nominal prices); Table 107: Greece Medicated Skin Products expenditure per capita, 2001-2006 (EUR, nominal prices); Table 108: Greece Medicated Skin Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 109: Greece Medicated Skin Products expenditure per capita, 2001-2006 (US$ nominal prices); Table 110: Greece Medicated Skin Products forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 111: Greece Other OTC Healthcare Products value, 2001-2006 (EUR m, nominal prices); Table 112: Greece Other OTC Healthcare Products value forecast, 2006-2011 (EUR m, nominal prices); Table 113: Greece Other OTC Healthcare Products value, 2001-2006 (US$ m nominal prices); Table 114: Greece Other OTC Healthcare Products value forecast, 2006-2011 (US$ m nominal prices); Table 115: Greece Other OTC Healthcare Products brand share, by value, 2005-2006 (%); Table 116: Greece Other OTC Healthcare Products value, by brand 2005-2006 (EUR m nominal prices); Table 117: Greece Other OTC Healthcare Products company share by value, 2005-2006 (%); Table 118: Greece Other OTC Healthcare Products value, by company, 2005-2006 (EUR m nominal prices); Table 119: Greece Other OTC Healthcare Products expenditure per capita, 2001-2006 (EUR, nominal prices); Table 120: Greece Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 121: Greece Other OTC Healthcare Products expenditure per capita, 2001-2006 (US$ nominal prices); Table 122: Greece Other OTC Healthcare Products forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 123: Greece Topical OTC Medicines value, 2001-2006 (EUR m, nominal prices); Table 124: Greece Topical OTC Medicines value forecast, 2006-2011 (EUR m, nominal prices); Table 125: Greece Topical OTC Medicines value, 2001-2006 (US$ m nominal prices); Table 126: Greece Topical OTC Medicines value forecast, 2006-2011 (US$ m nominal prices); Table 127: Greece Topical OTC Medicines brand share, by value, 2005-2006 (%); Table 128: Greece Topical OTC Medicines value, by brand 2005-2006 (EUR m nominal prices); Table 129: Greece Topical OTC Medicines company share by value, 2005-2006 (%); Table 130: Greece Topical OTC Medicines value, by company, 2005-2006 (EUR m nominal prices); Table 131: Greece Topical OTC Medicines expenditure per capita, 2001-2006 (EUR, nominal prices); Table 132: Greece Topical OTC Medicines forecast expenditure per capita, 2006-2011 (EUR, nominal prices); Table 133: Greece Topical OTC Medicines expenditure per capita, 2001-2006 (US$ nominal prices); Table 134: Greece Topical OTC Medicines forecast expenditure per capita, 2006-2011 (US$ nominal prices); Table 135: Global OTC Healthcare market value, 2006; Table 136: Global OTC Healthcare market split (value terms (US$ m), 2006) - Top 5 countries; Table 137: Leading players - Top 5 countries; Table 138: Greece OTC Healthcare new product launches (reports) and SKUs, by company 2006; Table 139: Greece OTC Healthcare new product launches (reports), by Ingredients 2006; Table 140: Greece OTC Healthcare new product launches (reports), by Package tags or Claims (Top 10 claims), 2006; Table 141: Greece OTC Healthcare new product launches (reports) - Recent 5 launches; Table 142: Greece Key Facts; Table 143: Greece population, by age group, 2000-2005 (millions); Table 144: Greece population forecast, by age group, 2005-2010 (millions); Table 145: Greece population, by gender, 2000-2005 (millions); Table 146: Greece population forecast, by gender, 2005-2010 (millions); Table 147: Greece real GDP, 2000-2005 (EUR bn, 2005 prices); Table 148: Greece real GDP forecast, 2005-2010 (EUR bn, 2005 prices); Table 149: Greece nominal GDP, 2000-2005 (EUR bn, nominal prices); Table 150: Greece real GDP, 2000-2005 (US$ bn, 2005 prices); Table 151: Greece real GDP forecast, 2005-2010 (US$ bn, 2005 prices); Table 152: Greece consumer price index, 2000-2005 (2000=100); Table 153: Greece consumer price index, 2005-2010 (2000=100); Table 154: Greece exchange rate, 2000-2005

More Greece Over-the-Counter Drugs Reports

OTC Pharmaceuticals – Greece – a snapshot (2011) by Mintel - Snapshots
OTC Pharmaceuticals in Greece by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers ...

The Pharmaceutical Market: Greece (pdf/xls) by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...

Pharmaceuticals – Greece – a snapshot (2011) by Mintel - Snapshots
Pharmaceuticals in Greece by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers prescription ...

Pharmaceuticals – Greece – a snapshot (2011) by Mintel - Snapshots
Pharmaceuticals in Greece by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers prescription ...

Incontinence in Greece by Euromonitor International
Incontinence products in Greece is currently subject to a rapid increase in the penetration of private label. All major retailers in the country are adding ...

See all reports like this >>

More Greece Reports

D&B Country RiskLine Report: Greece by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: Greece by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Greece: Country Profile by MarketLine
INTRODUCTION This report provides a detailed analysis on Greece, providing an overview of its political, economic and business environment, represented both textually and in graph and ...

2007 Greece Industry & Market Outlook by Barnes Reports
The 2007 Greece Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in Greece and 500+ minor industries ...

The Economic Competitiveness of Greece: Financials Returns, Labor Productivity and International Gaps by Icon Group International, Inc.
Is Greece competitive? With the globalization of markets, the increased mobility of corporate assets, and the need for productive human resources, this question has ...

See all reports like this >>

OTC Healthcare in Greece to 2011

Share this report

Other tasks

Research Assistance

Related Markets

Over-the-Counter Drugs Reports

Free Alert Me service